Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs

Eli Lilly has opened a $700 million R&D center in the Boston Seaport, boosting its RNA and DNA research capabilities and expanding its biotech-hosting Gateway Labs to the East Coast for the first time.